Advertisement

Topics

Saitama Daiichi Pharmaceutical Co., Ltd. Company Profile

20:03 EST 18th December 2018 | BioPortfolio

Since the founding of our company in 1963, we have steadily advanced in the areas of research and development and production, in the sincere pursuit of people's health. In this quest, we have become an industry leader in the research, development and production of ointments and liquid preparations, working diligently to meet ever-growing expectations. Some of our success stories include the ethical drugs, Miltax and Actosin Ointment as well as the molded cataplasms, Patecs series and Karoyan series.In recent years, there has been a growing interest in Drug Delivery System (DDS), among the domestic and foreign medical industries. We are actively at work in this field of research and development, especially Ttansdermal Therapeutic Systems (TTS, that provide lasting pharmacological effect with less side effects), with steady and specific progress toward practical application. Applying these technologies, we are engaged in commissioned research and development with other companies, both foreign and domestic. In order to serve the aging society of the future, we continue to further strengthen our research and development of drugs to treat and prevent diseases. In addition, our experience in production technology will allow us to make further advances in commissioned production.
Look to Saitama Daiichi Pharmaceutical Co., Ltd. for future progress.

Location

8-1, Minamisakae-cho
Kasukabe
Saitama
344-0057
Japan

Contact

Phone: 81-48-752-7151


News Articles [313 Associated News Articles listed on BioPortfolio]

Deals this week: Daiichi Sankyo, MannKind, Dova Pharmaceuticals

Daiichi Sankyo has transferred 41 of its long-listed products to Alfresa Pharma. The transaction also includes products manufactured by Daiichi...Read More... The post Deals this week: Daiichi Sankyo,...

Kitasato Daiichi Sankyo Vaccine to merge with Daiichi Sankyo

Daiichi Sankyo Company, Limited announced the scheme for the reorganization of Kitasato Daiichi Sankyo Vaccine Co, Ltd, a subsidiary of Daiichi Sankyo, into a subsidiary specializing in manufacturing ...

Daiichi Sankyo transfers 41 products to Alfresa Pharma

Daiichi Sankyo has announced plans to split and transfer its inventories to Alfresa Pharma, along with Japanese manufacturing and sales...Read More... The post Daiichi Sankyo transfers 41 products to ...

Daiichi Sankyo and Roche to Collaborate on New HER2 Low Companion Diagnostic Test

TOKYO and MUNICH and BASKING RIDGE, New Jersey, Nov. 27, 2018 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that it has entered into an agreement with...

EHA 2018: pivotal Phase III data for Daiichi Sankyo’s quizartinib

Daiichi Sankyo’s pivotal data presentation at this year’s European Hematology Association (EHA) annual meeting showed that its FLT3 inhibitor quizartinib...Read More... The post EHA 2018: pivotal ...

Daiichi Sankyo’s lymphoma therapy gets orphan drug status in Japan

Daiichi Sankyo has secured orphan drug designation from the Japan Ministry of Health, Labour and Welfare (MHLW) for its axicabtagene...Read More... The post Daiichi Sankyo’s lymphoma therapy gets or...

Daiichi Sankyo Presents Updated Results of [Fam-] Trastuzumab Deruxtecan (DS-8201) in Patients ...

TOKYO and MUNICH and BASKING RIDGE, N.J., Oct. 21, 2018 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that updated phase 1 safety Read more...

Glycotope GmbH: Daiichi Sankyo Enters Worldwide Licensing Agreement with Glycotope for Gatipotuzumab Antibody Drug Conjugate

TOKYO, BERLIN, BASKING RIDGE, NJ / ACCESSWIRE / July 30, 2018 / Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Glycotope GmbH (hereafter, Glycotope) have entered into an exclusive ...

Drugs and Medications [285 Associated Drugs and Medications listed on BioPortfolio]

Benicar [Daiichi Sankyo, Inc]

These highlights do not include all the information needed to use Benicar safely and effectively. See full prescribing information for Benicar. Benicar (olmesartan medoxomil) tablets Initial U.S. Appr...

Evoxac capsules(cevimeline hydrochloride) [Daiichi Sankyo Pharma Development]

EVOXAC Capsules(cevimeline hydrochloride)

Emetrol cherry [WellSpring Pharmaceutical Corporation]

Emetrol

Cetirizine hydrochloride [Pharmaceutical Associates, Inc.]

Cetirizine Hydrochloride Syrup

Giltuss total release [Gil Pharmaceutical Corp]

Drug Facts

PubMed Articles [515 Associated PubMed Articles listed on BioPortfolio]

Atmospheric activity concentration of Sr and Cs after the Fukushima Daiichi Nuclear Accident.

On 11 March 2011, the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident occurred and a large amount of radionuclides were discharged into the atmosphere. We have operated continuous aerosol sampl...

Re: Associations between Childhood Thyroid Cancer and External Radiation Dose after the Fukushima Daiichi Nuclear Power Plant Accident.

Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates.

Within (European) healthcare systems, the predominant goal for pharmaceutical expenditure is cost containment. This is due to a general belief among healthcare policy makers that pharmaceutical expend...

Applications of various analytical techniques in quality control of pharmaceutical excipients.

Although excipients are pharmacologically inert substances, still they are integral and significant ingredients of a pharmaceutical formulation. Their amount and concentration level along with the act...

Applications of proteomics in pharmaceutical research and development.

The significance of proteomics in the pharmaceutical industry has increased since overcoming initial difficulties. This review discusses recent proteomics publications from pharmaceutical companies to...

Clinical Trials [340 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Olmesartan Medoxomil Tablets 40 mg and Benicar® 40 mg Tablets of Daiichi Sankyo Inc., USA. Dosing periods of studies were ...

Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma

This study evaluates the non-inferiority of the new transdermal patch dosage form containing loxoprofen sodium (100 mg - Daiichi-Sankyo) in comparison with oral Loxonin® (60 mg tablet - D...

Clinical Impact of Pharmaceutical Consultations in Patients Treated for Chronic Obstructive Pulmonary Disease at Home

The implementation of pharmaceutical consultations in the city or at the hospital could modify the occurrence of exacerbations related to chronic obstructive pulmonary disease after return...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Companies [1065 Associated Companies listed on BioPortfolio]

Saitama Daiichi Pharmaceutical Co., Ltd.

Since the founding of our company in 1963, we have steadily advanced in the areas of research and development and production, in the sincere pursuit of people's health. In this quest, we have become a...

DAIICHI SANKYO EUROPE GmbH and SHARE

DAIICHI SANKYO is a global pharmaceutical company that focuses on researching and marketing innovative medications. The company was created in 2005 through the merger of two traditional Japanese e...

Daiichi Fine Chemical Co., Ltd

Daiichi Fine Chemical Co., Ltd. united the fine chemical business of Daiichi Pharmaceutical Group in October 2001.In the economic and social environment in which changes are expected to accelerate in ...

Daiichi Sankyo

The Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. ...

Daiichi Sankyo Company, Limited

Daiichi Sankyo Company, Limited, established in 2005 after the joint share transfer of two leading century-old Japanese pharmaceutical companies, is continuously generating innovative drugs that e...

More Information about "Saitama Daiichi Pharmaceutical Co., Ltd." on BioPortfolio

We have published hundreds of Saitama Daiichi Pharmaceutical Co., Ltd. news stories on BioPortfolio along with dozens of Saitama Daiichi Pharmaceutical Co., Ltd. Clinical Trials and PubMed Articles about Saitama Daiichi Pharmaceutical Co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Saitama Daiichi Pharmaceutical Co., Ltd. Companies in our database. You can also find out about relevant Saitama Daiichi Pharmaceutical Co., Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record